Validation of production system throughput potential and simulation experiment design

[EN] The throughput potential of a production system must be designed and validated before implementation.  Design includes creating product flow by setting the takt time consistent with meeting customer demand per time period and the average cycle time at each workstation being less than the takt time.  Creating product flow implies that the average waiting time preceding each workstation is no greater than the takt time.  Kingman’s equation for the average waiting time can be solved for the variation component given the utilization, and the cycle time.  The variation component consists of the variation in the demand and the variation in cycle time.  Given the variation in demand, the maximum allowable variation in cycle time to create flow can be determined.  Throughput potential validation is often performed using discrete event simulation modeling and experimentation.  If the variation in cycle time at every workstation is small enough to create flow, then a deterministic simulation experiment can be used.  An industrial example concerning a tier-1 automotive supplier with two possible production systems designs and various levels of variation in demand assumed is used to demonstrate the effectiveness of throughput validation using deterministic discrete event simulation modeling and experimentation.Standridge, C.; Wynne, M. (2021). Validation of production system throughput potential and simulation experiment design. International Journal of Production Management and Engineering. 9(1):15-23. https://doi.org/10.4995/ijpme.2021.14483OJS152391Atalan, A., Dönmez, C.C. (2020). Optimizing experimental simulation design for the emergency departments. Brazilian Journal of Operations & Production Management, 17(4), e2020854. https://doi.org/10.14488/BJOPM.2020.026Askin, R.G., Standridge, C.R. (1993). Modeling and analysis of manufacturing systems. New York: John Wiley and Sons.Dagkakis, G., Rotondo, A., Heavey, C. (2019). Embedding optimization with deterministic discrete event simulation for assignment of cross-trained operators: an assembly line case study. Computers and Operations Research, 111, 99-115. https://doi.org/10.1016/j.cor.2019.06.008Ferrin, D.M., Miller M.J., Muthler D. (2005). Lean sigma and simulation, so what's the correlation?, in Proceedings of the 2005 Winter Simulation Conference, IEEE, USA. Retrieved July 22, 2020 from: https://informs-sim.org/wsc05papers/249.pdfHopp, W.J., Spearman, M.L. (2011). Factory Physics: Foundations of manufacturing management, 3rd ed. Long Grove, IL: Waveland Press.Jayaraman, A., Gunal, A.K. (1997). Applications of discrete event simulation in the design of automotive powertrain manufacturing systems". In Proceedings of the 1997 Winter Simulation Conference, IEEE, USA. https://doi.org/10.1145/268437.268620Khan, S., Standridge, C.R. (2019). Aggregate simulation modeling with application to setting the CONWIP limit in an HMLV cell. International Journal of Industrial Engineering Computation, 10(2), 149-160. https://doi.org/10.5267/j.ijiec.2018.10.002Kingman, J.F.C. (1961). The single server queue in heavy traffic. Mathematical Proceedings of the Cambridge Philosophical Society, 57(4), 902. https://doi.org/10.1017/S0305004100036094Kleijnen, J.P.C. (2015). Design and analysis of simulation experiments. New York: Springer. https://doi.org/10.1007/978-3-319-18087-8Kleijnen, J.P.C., Standridge, C.R. (1988). Experimental design and regression analysis in simulation: an FMS case study. European Journal of Operations Research, 33, 257-261. https://doi.org/10.1016/0377-2217(88)90168-3Law, A.M. (2014). Simulation modeling and analysis, 5th ed. New York: McGraw-Hill.Little, J.D.C. (1961). A proof for the queuing formula: L = λW. Operations Research, 9(3), 383-387. https://doi.org/10.1287/opre.9.3.383Marvel, J.H., Standridge, C.R. (2009). A simulation enhanced lean design process. Journal of Industrial Engineering and Management, 2(1), 90-113. https://doi.org/10.3926/jiem.2009.v2n1.p90-113Mourtzis, D. (2019) Simulation in the design and operation of manufacturing systems: state of the art and new trends. International Journal of Production Research, 58(7), 1927-1949. https://doi.org/10.1080/00207543.2019.1636321Pinheiro, N.M.G, Cleto, M.G., Zattar, I.C., Muller, S.I.M.G. (2019). Performance evaluation of pulled, pushed and hybrid production through simulation: a case study. Brazilian Journal of Operations & Production Management, 16, 685-697. https://doi.org/10.14488/BJOPM.2019.v16.n4.a13Pritsker, A.A.B. (1989). Why simulation works. In Proceedings of the 1989 Winter Simulation Conference, IEEE, USA. https://doi.org/10.1145/76738.76739Puvanasvaran, P., Teoh, Y.S., Ito, K. (2020). Novel availability and performance ratio for internal transportation and manufacturing processes in job shop company. Journal of Industrial Engineering and Management, 13(1), 1-17. https://doi.org/10.3926/jiem.2755Sanchez, S.M., Sanchez, P.J., Wan, H. (2020). Work smarter, not harder: a tutorial on designing and conducting simulation experiments. In Proceedings of the 2020 Winter Simulation Conference, IEEE, USA. Retrieved December 23, 2020 from https://informs-sim.org/ wsc20papers/135.pdfSchruben, L. (1983). Simulation modeling with event graphs. Communications of the A.C.M., 26(11). https://doi.org/10.1145/182.358460Spearman, M.L., Woodruff, D.L., Hopp, W.J. (1990). CONWIP: A pull alternative to Kanban, International Journal of Production Research, 28(5), 879-894. https://doi.org/10.1080/00207549008942761Standridge, C.R. (2019). Introduction to production: philosophies, flow, and analysis. Allendale Michigan: Grand Valley State University Libraries. Retrieved July 22, 2020 from: https://scholarworks.gvsu.edu/books/22/Tapping, D., Luyster, T., Shuker, T. (2002). Value stream management. Boca Raton: CRC Press. https://doi.org/10.4324/9781482278163Tribastone, M., Vandin, A. (2018). Speeding up stochastic and deterministic simulation by aggregation: an advanced tutorial. . In Proceedings of the 2018 Winter Simulation Conference, IEEE, USA. https://doi.org/10.1109/WSC.2018.8632364Uriarte, A.G., Ng, A.H.C., Moris, M.U. (2020). Bringing together Lean and simulation: a comprehensive review, International Journal of Production Research, 58(1), 87-117. https://doi.org/10.1080/00207543.2019.1643512Zupan, H., Herakovic. N. (2015). Production line balancing with discrete event simulation: a case study", IFAC-PapersOnLine, 48(3), 2305- 2311. https://doi.org/10.1016/j.ifacol.2015.06.43

No neurocognitive advantage for immediate antiretroviral treatment in adults with greater than 500 CD4+ T-cell counts

OBJECTIVE: To compare the effect of immediate versus deferred antiretroviral treatment (ART) on neuropsychological test performance in treatment-naive HIV-positive adults with >500 CD4+ cells/μL. DESIGN: Randomized trial. METHODS: The START parent study randomized participants to commence immediate versus deferred ART until CD4+ <350 cells/μL. The START Neurology substudy used 8 neuropsychological tests, at baseline, months 4, 8, 12 and annually, to compare groups for changes in test performance. Test results were internally standardized to z-scores. The primary outcome was the average of the eight test z-scores (QNPZ-8). Mean changes in QNPZ-8 from baseline were compared by intent-to-treat using longitudinal mixed models. Changes from baseline to specific time points were compared using ANCOVA models. RESULTS: 592 participants had a median age of 34 years; median baseline CD4+ count of 629 cells/μL; the mean follow-up was 3.4 years. ART was used for 94% and 32% of accrued person-years in the immediate and deferred groups, respectively. There was no difference between the immediate and deferred ART groups in QNPZ-8 change through follow-up [-0.018 (95% CI: -0.062 to 0.027, p = 0.44)], or at any visit. However, QNPZ-8 scores increased in both arms during the first year, by 0.22 and 0.24, respectively (p < 0.001 for increase from baseline). CONCLUSIONS: We observed substantial improvement in neurocognitive test performance during the first year in both study arms, underlining the importance of using a control group in studies assessing neurocognitive performance over time. Immediate ART neither benefitted nor harmed neurocognitive performance in individuals with CD4+ cell counts above 500 cells/μL

Prevalence and Correlates of At-Risk Drinking Among Older Adults: The Project SHARE Study

At-risk drinking, excessive or potentially harmful alcohol use in combination with select comorbidities or medication use, affects about 10% of elderly adults and is associated with higher mortality. Yet, our knowledge is incomplete regarding the prevalence of different categories of at-risk drinking and their associations with patient demographics. To examine the prevalence and correlates of different categories of at-risk drinking among older adults. Cross-sectional analysis of survey data. Current drinkers ages 60 and older accessing primary care clinics around Santa Barbara, California (n = 3,308). At-risk drinkers were identified using the Comorbidity Alcohol Risk Evaluation Tool (CARET). At-risk alcohol use was categorized as alcohol use in the setting of 1) high-risk comorbidities or 2) high-risk medication use, and 3) excessive alcohol use alone. Adjusted associations of participant characteristics with at-risk drinking in each of the three at-risk categories and with at-risk drinking of any kind were estimated using logistic regression. Over one-third of our sample (34.7%) was at risk. Among at-risk individuals, 61.9% had alcohol use in the context of high-risk comorbidities, 61.0% had high-risk medication use, and 64.3% had high-risk alcohol behaviors. The adjusted odds of at-risk drinking of any kind were decreased and significant for women (odds ratio, OR = 0.41; 95% confidence interval: 0.35-0.48; p-value &lt; 0.001), adults over age 80 (OR = 0.55; CI: 0.43-0.72; p &lt; 0.001 vs. ages 60-64), Asians (OR = 0.40; CI: 0.20-0.80; p = 0.01 vs. Caucasians) and individuals with higher education levels. Similar associations were observed in all three categories of at-risk drinking. High-risk alcohol use was common among older adults in this large sample of primary care patients, and male Caucasians, those ages 60-64, and those with lower levels of education were most likely to have high-risk alcohol use of any type. Our findings could help physicians identify older patients at increased risk for problems from alcohol consumption

Peptide YY ablation in mice leads to the development of hyperinsulinaemia and obesity

Aims/hypothesis. Obese people exhibit reduced circulating peptide YY (PYY) levels, but it is unclear whether this is a consequence or cause of obesity. We therefore investigated the effect of Pyy ablation on energy homeostasis. Methods. Body composition, i.p. glucose tolerance, food intake and hypothalamic neuropeptide expression were determined in Pyy knock-out and wild-type mice on a normal or high-fat diet. Results. Pyy knock-out significantly increased bodyweight and increased fat mass by 50% in aged females on a normal diet. Male chow-fed Pyy −/− mice were resistant to obesity but became significantly fatter and glucose-intolerant compared with wild-types when fed a high-fat diet. Pyy knock-out animals exhibited significantly elevated fasting or glucose-stimulated serum insulin concentrations vs wild-types, with no increase in basal or fasting-induced food intake. Pyy knock-out decreased or had no effect on neuropeptide Y expression in the arcuate nucleus of the hypothalamus, and significantly increased proopiomelanocortin expression in this region. Male but not female knock-outs exhibited significantly increased growth hormone-releasing hormone expression in the ventromedial hypothalamus and significantly elevated serum IGF-I and testosterone levels. This sex difference in activation of the hypothalamo–pituitary somatotrophic axis by Pyy ablation may contribute to the resistance of chow-fed male knock-outs to late-onset obesity. Conclusions/interpretation. PYY signalling is important in the regulation of energy balance and glucose homeostasis, possibly via regulation of insulin release. Therefore reduced PYY levels may predispose to the development of obesity, particularly with ageing or under conditions of high-fat feeding

Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation

Background-In the general population, raised levels of inflammatory markers are stronger predictors of fatal than nonfatal cardiovascular disease (CVD) events. People with HIV have elevated levels of interleukin-6 (IL-6), high-sensitivity C-reactive protein (hsCRP), and D-dimer; HIV-induced activation of inflammatory and coagulation pathways may be responsible for their greater risk of CVD. Whether the enhanced inflammation and coagulation associated with HIV is associated with more fatal CVD events has not been investigated. Methods and Results-Biomarkers were measured at baseline for 9764 patients with HIV and no history of CVD. Of these patients, we focus on the 288 that experienced either a fatal (n=74) or nonfatal (n=214) CVD event over a median of 5 years. Odds ratios (ORs) (fatal versus nonfatal CVD) (95% confidence intervals [CIs]) associated with a doubling of IL-6, D-dimer, hsCRP, and a 1-unit increase in an IL-6 and D-dimer score, measured a median of 2.6 years before the event, were 1.39 (1.07 to 1.79), 1.40 (1.10 to 1.78), 1.09 (0.93 to 1.28), and 1.51 (1.15 to 1.97), respectively. Of the 214 patients with nonfatal CVD, 23 died during follow-up. Hazard ratios (95% CI) for all-cause mortality were 1.72 (1.28 to 2.31), 1.73 (1.27 to 2.36), 1.44 (1.15 to 1.80), and 1.88 (1.39 to 2.55), respectively, for IL-6, D-dimer, hsCRP, and the IL-6 and D-dimer score. Conclusions-Higher IL-6 and D-dimer levels reflecting enhanced inflammation and coagulation associated with HIV are associated with a greater risk of fatal CVD and a greater risk of death after a nonfatal CVD even

Increased indoleamine-2,3-dioxygenase activity is associated with poor clinical outcome in adults hospitalized with influenza in the INSIGHT FLU003Plus study

BACKGROUND: Indoleamine-2,3-dioxygenase (IDO) mediated tryptophan (TRP) depletion has antimicrobial and immuno-regulatory effects. Increased kynurenine (KYN)-to-TRP (KT) ratios, reflecting increased IDO activity, have been associated with poorer outcomes from several infections. METHODS: We performed a case-control (1:2; age and sex matched) analysis of adults hospitalized with influenza A(H1N1)pdm09 with protocol-defined disease progression (died/transferred to ICU/mechanical ventilation) after enrollment (cases) or survived without progression (controls) over 60 days of follow-up. Conditional logistic regression was used to analyze the relationship between baseline KT ratio and other metabolites and disease progression. RESULTS: We included 32 cases and 64 controls with a median age of 52 years; 41% were female, and the median durations of influenza symptoms prior to hospitalization were 8 and 6 days for cases and controls, respectively (P = .04). Median baseline KT ratios were 2-fold higher in cases (0.24 mM/M; IQR, 0.13-0.40) than controls (0.12; IQR, 0.09-0.17; P ≤ .001). When divided into tertiles, 59% of cases vs 20% of controls had KT ratios in the highest tertile (0.21-0.84 mM/M). When adjusted for symptom duration, the odds ratio for disease progression for those in the highest vs lowest tertiles of KT ratio was 9.94 (95% CI, 2.25-43.90). CONCLUSIONS: High KT ratio was associated with poor outcome in adults hospitalized with influenza A(H1N1)pdm09. The clinical utility of this biomarker in this setting merits further exploration. CLINICALTRIALSGOV IDENTIFIER: NCT01056185

Effect of Iron Therapy on Platelet Counts in Patients with Inflammatory Bowel Disease-Associated Anemia

Secondary thrombocytosis is a clinical feature of unknown significance. In inflammatory bowel disease (IBD), thrombocytosis is considered a marker of active disease; however, iron deficiency itself may trigger platelet generation. In this study we tested the effect of iron therapy on platelet counts in patients with IBD-associated anemia.Platelet counts were analyzed before and after iron therapy from four prospective clinical trials. Further, changes in hemoglobin, transferrin saturation, ferritin, C-reactive protein, and leukocyte counts, before and after iron therapy were compared. In a subgroup the effect of erythropoietin treatment was tested. The results were confirmed in a large independent cohort (FERGIcor).A total of 308 patient records were available for the initial analysis. A dose-depended drop in platelet counts (mean 425 G/L to 320 G/L; p<0.001) was found regardless of the type of iron preparation (iron sulphate, iron sucrose, or ferric carboxymaltose). Concomitant erythropoietin therapy as well as parameters of inflammation (leukocyte counts, C-reactive protein) had no effect on the change in platelet counts. This effect of iron therapy on platelets was confirmed in the FERGIcor study cohort (n=448, mean platelet counts before iron therapy: 383 G/L, after: 310 G/L, p<0.001).Iron therapy normalizes elevated platelet counts in patients with IBD-associated anemia. Thus, iron deficiency is an important pathogenetic mechanism of secondary thrombocytosis in IBD

Effects of Intermittent IL-2 Alone or with Peri-Cycle Antiretroviral Therapy in Early HIV Infection: The STALWART Study

The Study of Aldesleukin with and without antiretroviral therapy (STALWART) evaluated whether intermittent interleukin-2 (IL-2) alone or with antiretroviral therapy (ART) around IL-2 cycles increased CD4+ counts compared to no therapy

Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection: A case control study

Introduction: The use of anti-retroviral therapy (ART) has dramatically reduced HIV-1 associated morbidity and mortality. However, HIV-1 infected individuals have increased rates of morbidity and mortality compared to the non-HIV-1 infected population and this appears to be related to end-organ diseases collectively referred to as Serious Non-AIDS Events (SNAEs). Circulating miRNAs are reported as promising biomarkers for a number of human disease conditions including those that constitute SNAEs. Our study sought to investigate the potential of selected miRNAs in predicting mortality in HIV-1 infected ART treated individuals. Materials and Methods: A set of miRNAs was chosen based on published associations with human disease conditions that constitute SNAEs. This case: control study compared 126 cases (individuals who died whilst on therapy), and 247 matched controls (individuals who remained alive). Cases and controls were ART treated participants of two pivotal HIV-1 trials. The relative abundance of each miRNA in serum was measured, by RTqPCR. Associations with mortality (all-cause, cardiovascular and malignancy) were assessed by logistic regression analysis. Correlations between miRNAs and CD4+ T cell count, hs-CRP, IL-6 and D-dimer were also assessed. Results: None of the selected miRNAs was associated with all-cause, cardiovascular or malignancy mortality. The levels of three miRNAs (miRs -21, -122 and -200a) correlated with IL-6 while miR-21 also correlated with D-dimer. Additionally, the abundance of miRs -31, -150 and -223, correlated with baseline CD4+ T cell count while the same three miRNAs plus miR- 145 correlated with nadir CD4+ T cell count. Discussion: No associations with mortality were found with any circulating miRNA studied. These results cast doubt onto the effectiveness of circulating miRNA as early predictors of mortality or the major underlying diseases that contribute to mortality in participants treated for HIV-1 infection

High-level classification of the Fungi and a tool for evolutionary ecological analyses

High-throughput sequencing studies generate vast amounts of taxonomic data. Evolutionary ecological hypotheses of the recovered taxa and Species Hypotheses are difficult to test due to problems with alignments and the lack of a phylogenetic backbone. We propose an updated phylum-and class-level fungal classification accounting for monophyly and divergence time so that the main taxonomic ranks are more informative. Based on phylogenies and divergence time estimates, we adopt phylum rank to Aphelidiomycota, Basidiobolomycota, Calcarisporiellomycota, Glomeromycota, Entomophthoromycota, Entorrhizomycota, Kickxellomycota, Monoblepharomycota, Mortierellomycota and Olpidiomycota. We accept nine subkingdoms to accommodate these 18 phyla. We consider the kingdom Nucleariae (phyla Nuclearida and Fonticulida) as a sister group to the Fungi. We also introduce a perl script and a newick-formatted classification backbone for assigning Species Hypotheses into a hierarchical taxonomic framework, using this or any other classification system. We provide an example of testing evolutionary ecological hypotheses based on a global soil fungal data set.Peer reviewe